BETABiohacksAI is a research tool for informational purposes only. All outputs are computational hypothesis candidates — not confirmed mechanisms, not medical advice, and not a substitute for professional medical judgment. Independent experimental validation is always required.
BiohacksAI is an evolving scientific literature platform. New compounds and evidence are indexed continuously.
B
○

Motesanib

0+ PubMed studies analyzed

Similar Compounds by Shared Targets

The following compounds share molecular targets with Motesanib, based on binding affinity data from BindingDB and ChEMBL. Sorted by shared target overlap.

raf
34 shared targets
brivanib
24 shared targets
cediranib
33 shared targets
doramapimod
33 shared targets
masitinib
18 shared targets
saracatinib
24 shared targets
vatalanib
15 shared targets
vandetanib
36 shared targets
ponatinib
27 shared targets
tivozanib
19 shared targets
Loading evidence profile...

This evidence profile for Motesanib is generated deterministically from 0 PubMed-indexed studies. All data is corpus-verified with Merkle proofs. BiohacksAI does not provide medical advice. Always consult a healthcare professional before starting any supplement regimen.

Data source: PubMed/MEDLINE (NLM). Corpus version: v20260227-01. Patent pending (EVE-PAT-2026-001). © 2026 Organiq Sweden AB.